Search - tctmd.com

Displaying 221 - 240 of 406

Sort: Relevancy | Date

Presentation THT 2026

Clinical Evaluation Of The Vsling™ Device For Ventricular Repair In Patients With Heart Failure

Presenter: Gregg W. Stone

March 03, 2026

Presentation THT 2026

LVADs to Jumpstart the Process of Myocardial Regeneration

Presenter: Stavros G. Drakos

March 02, 2026

Presentation THT 2026

AI-Enabled Real-Time Shock Navigator for Precision Decision-Making in Cardiogenic Shock

Presenter: Juliana Giorgi

March 02, 2026

Presentation THT 2026

Ethics, Bias, and Regulation: Are We Ready for AI at the Bedside?

Presenter: Ami B. Bhatt

March 02, 2026

Presentation THT 2026

The CHILD Trial: Phase I Randomized Study of Cardiac Stem Cells in Patients with Hypoplastic Left Heart Syndrome

Presenter: Sunjay Kaushal

March 02, 2026

Presentation THT 2026

Longitudinal ImmuKnow Monitoring One Year After Heart Transplant: Associations with Rejection, Infection, and Cardiac Allograft Vasculopathy 

Presenter: David Golombeck

March 02, 2026

Presentation THT 2026

Comparing risk of in-hospital mortality in patient with cardiogenic shock due to ACS or HF using CSWG-SCAI criteria

Presenter: Kiana Shivaee

March 02, 2026

Presentation THT 2026

Engineering the Future: Human-AI Interfaces in Heart Failure Devices

Presenter: Ilan Richter

March 02, 2026

Presentation THT 2026

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

Presenter: Eugene Jiaxian Wang

March 02, 2026

Presentation THT 2026

Comparing Predictors of Readmission in LVAD Patients Bridged to Transplant: Psoas Muscle Index versus Pre-Albumin

Presenter: Matthew Ramm

March 02, 2026

Presentation THT 2026

Hemodynamic TEE for Integrated Multimodal Assessment of RV Function: A Prospective Feasibility Study

Presenter: Ahmed Aburahma

March 02, 2026

Presentation THT 2026

AI in the Trenches: Lessons From Clinical Trial Optimization

Presenter: Jonathan Cunningham

March 02, 2026

Presentation THT 2026

Heart Transplantation in Adults Over 70 Years: National Trends and Center-Level Variability

Presenter: Dena E. Hayes

March 02, 2026

Presentation THT 2026

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Presenter: Kathy Ivey

March 02, 2026

Presentation THT 2026

Intraaortic Balloon Pump in Cardiogenic Shock: Did We Rush to Bury It?

Presenter: Maya Guglin

March 02, 2026

Presentation THT 2026

Risk Redefined: Predictive Modeling and the AI-enabled HF Clinic

Presenter: Tariq Ahmad

March 02, 2026

Presentation THT 2026

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Presenter: James F. Martin

March 02, 2026

Presentation THT 2026

Characterizing Hemodynamic Phenotypes In Patients Not Meeting Diagnostic Criteria for Primary Graft Dysfunction

Presenter: Caroline Magro

March 02, 2026

Presentation THT 2026

Adjunctive Supersaturated Oxygen Therapy Following PCI in Acute Coronary Syndrome With Cardiogenic Shock: A Randomized Study

Presenter: Sanchit Kundal

March 02, 2026

Presentation THT 2026

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Presenter: Eric D. Adler

March 02, 2026

Advertisement

Clinical Evaluation Of The Vsling™ Device For Ventricular Repair In Patients With Heart Failure

LVADs to Jumpstart the Process of Myocardial Regeneration

AI-Enabled Real-Time Shock Navigator for Precision Decision-Making in Cardiogenic Shock

Ethics, Bias, and Regulation: Are We Ready for AI at the Bedside?

The CHILD Trial: Phase I Randomized Study of Cardiac Stem Cells in Patients with Hypoplastic Left Heart Syndrome

Longitudinal ImmuKnow Monitoring One Year After Heart Transplant: Associations with Rejection, Infection, and Cardiac Allograft Vasculopathy

Comparing risk of in-hospital mortality in patient with cardiogenic shock due to ACS or HF using CSWG-SCAI criteria

Engineering the Future: Human-AI Interfaces in Heart Failure Devices

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

Comparing Predictors of Readmission in LVAD Patients Bridged to Transplant: Psoas Muscle Index versus Pre-Albumin

Hemodynamic TEE for Integrated Multimodal Assessment of RV Function: A Prospective Feasibility Study

AI in the Trenches: Lessons From Clinical Trial Optimization

Heart Transplantation in Adults Over 70 Years: National Trends and Center-Level Variability

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Intraaortic Balloon Pump in Cardiogenic Shock: Did We Rush to Bury It?

Risk Redefined: Predictive Modeling and the AI-enabled HF Clinic

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Characterizing Hemodynamic Phenotypes In Patients Not Meeting Diagnostic Criteria for Primary Graft Dysfunction

Adjunctive Supersaturated Oxygen Therapy Following PCI in Acute Coronary Syndrome With Cardiogenic Shock: A Randomized Study

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content